Yu Fan

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 18, 2026), Yu Fan reported 8 stock positions worth $97.0 million. Its top holding was Kestra Medical Technologies (KMTS) at 46.9% of the portfolio, followed by Alumis (ALMS, 17.6%) and Ceribell (CBLL, 10.4%). Compared with Q4 2025, it opened 3 new positions and reduced 1. The biggest buy was a new position in Perspective Therapeutics (CATX) and the biggest sale Alumis (ALMS, shares −2%).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001668029
Portfolio Value
$97.0M (Q1 2026)
SEC Filing
0001193125-26-227546 ↗ filed May 18, 2026

Holdings Value

0$50.0M$100.0M$150.0M Q1 2024: $72.5M Q1 2024 Q2 2024: $76.5M Q2 2024 Q3 2024: $32.5M Q3 2024 Q4 2024: $53.2M Q4 2024 Q1 2025: $97.3M Q1 2025 Q2 2025: $73.2M Q2 2025 Q3 2025: $76.9M Q3 2025 Q4 2025: $92.3M Q4 2025 Q1 2026: $97.0M $97.0M Q1 2026 Q2 2026: $107.9M Q2 2026

Holdings 8 stocks · $97.0M

KMTS Kestra Medical Technologies 46.89% 2,282,519 $45.5M No change
ALMS Alumis Inc. 17.64% 776,845 $17.1M Reduce -1.6%
CBLL Ceribell Inc. 10.38% 549,448 $10.1M No change
IVA Inventiva SA - ADR 8.58% 1,500,000 $8.3M No change
WHWK Whitehawk Therapeutics Inc. 7.36% 2,070,000 $7.1M No change
CATX Perspective Therapeutics Inc. 4.54% 1,055,409 $4.4M New
PMN Promis Neurosciences Inc. 4.32% 329,760 $4.2M New
ABTC American Bitcoin Corp. 0.29% 308,076 $285K New

Portfolio Sells Q4 2025 → Q1 2026

ALMS Alumis Inc. Reduce -1.6% 17.64% +9.29

Portfolio Buys Q4 2025 → Q1 2026

CATX Perspective Therapeutics Inc. New 4.54% +4.54
PMN Promis Neurosciences Inc. New 4.32% +4.32
ABTC American Bitcoin Corp. New 0.29% +0.29

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 8$107.9MKMTS, WHWK, ALMS, CBLL, IVA
Q1 2026 8$97.0MKMTS, ALMS, CBLL, IVA, WHWK
Q4 2025 5$92.3MKMTS, CBLL, ALMS, IVA, WHWK
Q3 2025 4$76.9MKMTS, CBLL, WHWK, ALMS
Q2 2025 5$73.2MKMTS, CBLL, WHWK, CRGX, ALMS
Q1 2025 9$97.3MKMTS, CBLL, ALMS, CGON, CRGX
Q4 2024 7$53.2MCBLL, CRGX, ALMS, CGON, CSTL
Q3 2024 6$32.5MCRGX, ALMS, CGON, CSTL, PYXS
Q2 2024 6$76.5MCGON, CRGX, ALMS, CSTL, PYXS
Q1 2024 5$72.5MPRENETICS GLOBAL LTD, AEGLEA BIOTHERAPEUTICS INC, SONENDO INC, SGMT, PYXS